e-paper
 

Oct 31, 2020-Saturday

select city

Metro cities - Delhi, Mumbai, Chennai, Kolkata

Other cities - Noida, Gurgaon, Bengaluru, Hyderabad, Bhopal , Chandigarh , Dehradun, Indore, Jaipur, Lucknow, Patna, Ranchi

Saturday, Oct 31, 2020
ADVERTISEMENT

Pfizer

The UK’s drug regulator has started accelerated reviews of Covid-19 vaccines under development from Pfizer Inc. and AstraZeneca Plc, as Britain gets ready to approve the first successful shot as quickly as possible.
UK accelerates reviews of Pfizer and Astra-Oxford Covid-19 vaccines
Oct 30, 2020 21:47
The UK’s drug regulator has started accelerated reviews of Covid-19 vaccines under development from Pfizer Inc. and AstraZeneca Plc, as Britain gets ready to approve the first successful shot as quickly as possible. read more
Pfizer estimated a revenue hit of $500 million connected to Covid-19 due to lower pharma demand in China and fewer wellness visits from patients in the US.
Pfizer says Covid-19 vaccine may yet be possible in 2020
Oct 29, 2020 07:34
Pfizer estimated a revenue hit of $500 million connected to Covid-19 due to lower pharma demand in China and fewer wellness visits from patients in the US. read more
Chief Executive Albert Bourla said after it has enough data for the analysis, it typically takes 5 to 7 days before the company can publicly release the data, meaning it is likely to happen after the election.
Pfizer says no Covid-19 vaccine data yet, could be week or more before it reports
Oct 27, 2020 22:15
Chief Executive Albert Bourla said after it has enough data for the analysis, it typically takes 5 to 7 days before the company can publicly release the data, meaning it is likely to happen after the election. read more
British health secretary Matt Hancock said a vaccine was not yet ready but he was preparing logistics for a possible roll-out mostly in the first half of 2021
Oxford vaccine tests raise hopes
Oct 27, 2020 00:09
British health secretary Matt Hancock said a vaccine was not yet ready but he was preparing logistics for a possible roll-out mostly in the first half of 2021 read more
Reusable temperature-controlled containers have been designed by the company. Each of this boxes can hold 1,000 to 5,000 vaccine doses. The temperature will be minus 70 degrees Celsius.
350 large freezers, football ground-size land: Inside Pfizer’s vaccine delivery system
Oct 22, 2020 15:34
Reusable temperature-controlled containers have been designed by the company. Each of this boxes can hold 1,000 to 5,000 vaccine doses. The temperature will be minus 70 degrees Celsius. read more
Pfizer Inc expects to provide safety data and file for authorization of the Covid-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vaccine until after the Nov. 3 U.S. presidential election.
Pfizer sees emergency use filing for Covid-19 vaccine after US election
Oct 16, 2020 17:48
Pfizer Inc expects to provide safety data and file for authorization of the Covid-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vaccine until after the Nov. 3 U.S. presidential election. read more
Several companies are also using this approach to develop a vaccine, including U.S. companies Moderna and Pfizer whose candidates have reached late-stage trials.
Sanofi reports positive animal test results for potential Covid-19 vaccine
Oct 15, 2020 17:51
Several companies are also using this approach to develop a vaccine, including U.S. companies Moderna and Pfizer whose candidates have reached late-stage trials. read more
Pfizer and BioNTech chose their candidate from a slate of four contenders, all of which relied on messenger RNA technology designed to teach the body’s cells to become vaccine factories in their own right.
Pfizer, BioNTech vaccine trial remains on track, says CEO
Oct 15, 2020 14:04
Pfizer and BioNTech chose their candidate from a slate of four contenders, all of which relied on messenger RNA technology designed to teach the body’s cells to become vaccine factories in their own right. read more
On Monday, the company said it had received permission from the Food and Drug Administration to include adolescents aged 12 through 15 in its global Covid-19 vaccine study.
Pfizer modifies protocol for virus vaccine study to include more young participants
Oct 13, 2020 10:17
On Monday, the company said it had received permission from the Food and Drug Administration to include adolescents aged 12 through 15 in its global Covid-19 vaccine study. read more
Companies from AstraZeneca Plc to Moderna Inc. and Pfizer Inc. (working with BioNTech SE) are all in hot pursuit of a vaccine, with Pfizer among the likeliest to file for early approval, perhaps as soon as this month.
Rushing a Covid-19 vaccine is a terrible idea. Here’s why
Oct 13, 2020 04:05
Companies from AstraZeneca Plc to Moderna Inc. and Pfizer Inc. (working with BioNTech SE) are all in hot pursuit of a vaccine, with Pfizer among the likeliest to file for early approval, perhaps as soon as this month. read more
Drugmaker Pfizer has suggested it could have data on the safety and effectiveness of its vaccine before Election Day and a number of variables would still have to align for the company to submit, and the FDA to review and approve, a vaccine application before November 3.
White House cancels updated FDA guidelines on Covid-19 vaccine approval: What it means
Oct 06, 2020 14:50
Drugmaker Pfizer has suggested it could have data on the safety and effectiveness of its vaccine before Election Day and a number of variables would still have to align for the company to submit, and the FDA to review and approve, a vaccine application before November 3. read more
All four companies — Pfizer, Moderna, AstraZeneca, and Johnson & Johnson — are also signatories to a pledge to ensure “high ethical standards and sound scientific principles”, and to not seek regulatory approval for their vaccines till clinical trials on tens of thousands of individuals show them (the vaccines) to be effective and safe.
Covid-19: What you need to know today
Sep 25, 2020 02:15
All four companies — Pfizer, Moderna, AstraZeneca, and Johnson & Johnson — are also signatories to a pledge to ensure “high ethical standards and sound scientific principles”, and to not seek regulatory approval for their vaccines till clinical trials on tens of thousands of individuals show them (the vaccines) to be effective and safe. read more
Pfizer would know whether their vaccine candidate is effective by end of October,
Covid-19 vaccine: When will US get its first vaccine?
Sep 24, 2020 08:40
Pfizer would know whether their vaccine candidate is effective by end of October, read more
When the vaccine will be found 50 per cent effective, Astrazeneca will apply to the government for early release of the vaccine for emergency use.
‘A vaccine with 50 per cent effectiveness’: Astrazeneca releases 111-page Covid-19 vaccine trial blueprint | All you need to know
Sep 20, 2020 18:50
When the vaccine will be found 50 per cent effective, Astrazeneca will apply to the government for early release of the vaccine for emergency use. read more
The vaccine race has become deeply politicized in the US in the run-up to the presidential election in November, as President Donald Trump touts a quick vaccine in response to criticism of his handling of the pandemic.
Moderna shares Covid-19 vaccine trial blueprints, Pfizer follows
Sep 18, 2020 09:31
The vaccine race has become deeply politicized in the US in the run-up to the presidential election in November, as President Donald Trump touts a quick vaccine in response to criticism of his handling of the pandemic. read more

trending topics